French health regulators intend to ask the European Union to restrict newer varieties of birth control pills, over concerns they may cause blood clots.
A Reuters story says all birth control pills are associated with a risk of blood clots, but a number of studies show that newer types carry a higher risk.
For examples, studies have suggested pills with the compound drospirenone – ...
continue reading...
A story in U.K. newspaper The Mirror concerns the higher risk of “third-generation” contraceptive pills, compared to ones that have been on the market for longer.
It concerns two different studies by the Boston University School of Medicine into two different types of birth control. The results were published in the British Medical Journal.
The studies concluded that “the difference in threat was dramatic” between older oral contraceptives containing levonorgestrel and relatively ...
continue reading...Switzerland’s largest health insurer announced that it’s supporting a young woman who has filed suit against pharmaceutical giant Bayer, claiming the company’s Yasmin birth control pill caused a pulmonary embolism that left her severely disabled.
The insurer, CSS, will be a joint plaintiff in a lawsuit seeking reimbursement for medical expenses. According to a Reuters article, the young woman’s medical treatment has amounted to about $648,600.
She reportedly suffered a pulmonary embolism ...
continue reading...
The U.S. Food and Drug Administration has approved Skyla, an intrauterine device manufactured by Bayer.
A Reuters report describes Skyla as a T-shaped polyethylene device that releases low doses of the hormone progestin, and is designed to prevent pregnancy for three years. It’s the first new device of its type to be approved in 12 years.
Recently, Bayer has had problems with other birth control products.
Last year, the company spent $750 million ...
continue reading...A public health watchdog group in France is calling for doctors to severely cut back on the amounts of newer birth control pills they prescribe, citing the risk of blood clots.
An account in South African newspaper The Times quotes National Drugs Safety Agency Director General Dominique Maraninchi as saying that older types of birth control pills should be the standard.
Maraninchi says doctors should prescribe the newer pills only “in very ...
continue reading...According to Reuters, a recent study from Israel “adds evidence” to the claim that birth control pills containing the compound drospirenone carry a higher risk of blood clots than other types of oral contraceptives on the market.
Drospirenone, a synthetic hormone, is a component of relatively new birth control pills including Yasmin, read more.... --> continue reading...
